Source: International Brazilian Journal of Urology. Unidade: FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, COMORBIDADE
- ABNT MALUF, Fernando et al. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician’s perception according to patient comorbidities. International Brazilian Journal of Urology, v. 47, n. 2, p. 359-373, 2021Tradução . . Disponível em: https://doi.org/10.1590/S1677-5538.IBJU.2020.0249. Acesso em: 26 out. 2025.
- APA Maluf, F., Soares, A., Avanço, G., Hada, A. L., Cardoso, A. P. G., Carneiro, A., et al. (2021). Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician’s perception according to patient comorbidities. International Brazilian Journal of Urology, 47( 2), 359-373. doi:10.1590/S1677-5538.IBJU.2020.0249
- NLM Maluf F, Soares A, Avanço G, Hada AL, Cardoso APG, Carneiro A, Herchenhorn D, Jardim DLF, Schütz FAB, Kater FR, Reis RB dos. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician’s perception according to patient comorbidities [Internet]. International Brazilian Journal of Urology. 2021 ; 47( 2): 359-373.[citado 2025 out. 26 ] Available from: https://doi.org/10.1590/S1677-5538.IBJU.2020.0249
- Vancouver Maluf F, Soares A, Avanço G, Hada AL, Cardoso APG, Carneiro A, Herchenhorn D, Jardim DLF, Schütz FAB, Kater FR, Reis RB dos. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician’s perception according to patient comorbidities [Internet]. International Brazilian Journal of Urology. 2021 ; 47( 2): 359-373.[citado 2025 out. 26 ] Available from: https://doi.org/10.1590/S1677-5538.IBJU.2020.0249
 
                     
                    
 
    		 
    		